Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideto Ueki

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 22, 2022
Efficacy of preoperative cine magnetic resonance imaging in evaluation of adhesion of renal cancer thrombus to inferior vena cava wallHideto Ueki, Tomoaki Terakawa, Yoshiko Ueno, et al.
BJU International|July 22, 2025
Developing an artificial intelligence model for phase recognition in robot-assisted radical prostatectomyHideto Ueki, Munenori Uemura, Kiyoyuki Chinzei, et al.
The Prostate|September 16, 2024
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, et al.
International Journal of Clinical Oncology|May 27, 2026
Comparison of effectiveness and safety of pembrolizumab plus lenvatinib versus nivolumab plus cabozantinib for metastatic renal cell carcinoma: a real-world studyTaisuke Tobe, Jun Teishima, Yoshie Mita, et al.
Oncology Letters|October 9, 2023
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 6, 2024
Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 3, 2025
Time to Oligoprogression From the Initiation of the Most Recent Systemic Treatment Is Associated With the Outcome of Progressive Site-Directed Therapy for Castration-Resistant Prostate CancerNaoki Matsuyama, Kotaro Suzuki, Taisuke Tobe, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 22, 2022
Efficacy of preoperative cine magnetic resonance imaging in evaluation of adhesion of renal cancer thrombus to inferior vena cava wallHideto Ueki, Tomoaki Terakawa, Yoshiko Ueno, et al.
BJU International|July 22, 2025
Developing an artificial intelligence model for phase recognition in robot-assisted radical prostatectomyHideto Ueki, Munenori Uemura, Kiyoyuki Chinzei, et al.
The Prostate|September 16, 2024
Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53Hideto Ueki, Naoe Jimbo, Tomoaki Terakawa, et al.
International Journal of Clinical Oncology|May 27, 2026
Comparison of effectiveness and safety of pembrolizumab plus lenvatinib versus nivolumab plus cabozantinib for metastatic renal cell carcinoma: a real-world studyTaisuke Tobe, Jun Teishima, Yoshie Mita, et al.
Oncology Letters|October 9, 2023
The impact of primary region resection on the therapeutic outcome of combination regimens for metastatic renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 6, 2024
Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinomaJun Teishima, Takuto Hara, Taisuke Tobe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 3, 2025
Time to Oligoprogression From the Initiation of the Most Recent Systemic Treatment Is Associated With the Outcome of Progressive Site-Directed Therapy for Castration-Resistant Prostate CancerNaoki Matsuyama, Kotaro Suzuki, Taisuke Tobe, et al.
Pageof 5